DEF 14A

Company

RIGEL PHARMACEUTICALS INC

Filed

May 19, 2003

Period of Report

June 20, 2003

Accession Number

0001047469-03-019117

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →